Does OXALIPLATIN Cause Second primary malignancy? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Second primary malignancy have been filed in association with OXALIPLATIN (Oxaliplatin). This represents 0.2% of all adverse event reports for OXALIPLATIN.
86
Reports of Second primary malignancy with OXALIPLATIN
0.2%
of all OXALIPLATIN reports
12
Deaths
19
Hospitalizations
How Dangerous Is Second primary malignancy From OXALIPLATIN?
Of the 86 reports, 12 (14.0%) resulted in death, 19 (22.1%) required hospitalization, and 9 (10.5%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OXALIPLATIN. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does OXALIPLATIN Cause?
Diarrhoea (4,963)
Nausea (4,250)
Neuropathy peripheral (3,662)
Off label use (3,603)
Neutropenia (3,391)
Vomiting (3,383)
Disease progression (3,370)
Thrombocytopenia (2,886)
Dyspnoea (2,779)
Pyrexia (2,269)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which OXALIPLATIN Alternatives Have Lower Second primary malignancy Risk?
OXALIPLATIN vs OXAPROZIN
OXALIPLATIN vs OXAZEPAM
OXALIPLATIN vs OXCARBAZEPINE
OXALIPLATIN vs OXITRIPTAN
OXALIPLATIN vs OXOMEMAZINE